A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms.

Authors:
Molderings GJ; Afrin LB.

Journal:
Naunyn Schmiedebergs Arch Pharmacol

Publication Year: 2023

DOI:
10.1007/s00210-023-02545-y

PMCID:
PMC10567897

PMID:
37243761

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Naunyn Schmiedebergs Arch Pharmacol

Abbreviation: Naunyn Schmiedebergs Arch Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Agomelatine improves memory and learning impairments in a rat model of LPS-induced neurotoxicity by…
Abdelaziz M; Mohamed AF; Zaki HF and 1 more (2023) - Transparency Score: 3/6
A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medica…
Sukkarieh HH; Khokhar AA; Bustami RT and 3 more (2023) - Transparency Score: 2/6
A review of the bioactive components and pharmacological properties of Lavandula species.
Batiha GE; Teibo JO; Wasef L and 7 more (2023) - Transparency Score: 3/6
Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 ce…
Zheng J; Gong S; Wu G and 9 more (2023) - Transparency Score: 3/6
Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition …
Malyla V; De Rubis G; Paudel KR and 4 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalNot applicable Competing interestsDr. Molderings is chief medical officer of the start-up company MC Sciences, Ltd. Dr. Afrin is an uncompensated volunteer medical advisor to the start-up company MC Sciences Ltd. Competing interests Dr. Molderings is chief medical officer of the start-up company MC Sciences, Ltd. Dr. Afrin is an uncompensated volunteer medical advisor to the start-up company MC Sciences Ltd."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. The investigations were supported by a grant of the Förderclub Mastzellforschunge.V."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025